EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases

Ahmed E. Salem, Hazem Abosheaishaa, Sarah Meribout, Morad Zaaya, Carla Barberan Parraga, Kantash Kumar, Aye Cherry, Mohammed Abusuliman, Mohamed Eldesouki, Omar Abdelhalim, Yuriy Tsirlin, Aaron Z. Tokayer

ASIDE Gastroenterology · 2025

DOI: 10.71079/aside.gi.09242544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ASIDE Gastroenterology, 2025. Verfasst von Ahmed E. Salem und 11 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Esophageal stent placement is a vital, minimally invasive procedure for alleviating dysphagia and enabling smoother food passage. It offers immediate relief, reduces hospital stays, and enhances quality of life for high-risk patients. Effective for both malignant and benign conditions, stenting is cost-efficient and requires skilled professionals for optimal outcomes. This study examines outcomes of various stent types in esophageal cancer patients, evaluating efficacy, safety, and quality-of-life impacts.

Methods

Between January and December 2022, 183 patients with esophageal cancer were enrolled from three tertiary healthcare facilities. Patients were divided into three groups based on the esophageal stent used: self-expanding metallic stents (SEMS, n = 84), self-expanding plastic stents (SEPS, n = 61), and fully covered self-expanding metallic stents (FCSEMS, n = 38). All stent placements were performed under endoscopic guidance, with follow-up assessments at 1 week, 1 month, 3 months, and 6 months to evaluate stent patency, dysphagia relief, and complications.

Results

Technical success rates were high: SEMS 96.4%, SEPS 95.1%, and FCSEMS 97.4%. Immediate dysphagia relief occurred in 87.4% of patients. FCSEMS had a significantly longer median patency duration (8.0 months) compared to SEMS (6.3 months) and SEPS (5.6 months). Additionally, SEPS exhibited a higher migration rate (13.1%), while overall complications were noted in 18.0% of patients.

Conclusions

Esophageal stent placement effectively palliates dysphagia in cancer patients. FCSEMS shows advantages with prolonged patency, yet careful stent selection is essential to optimize patient outcomes. These findings underscore the importance of individualized treatment planning and regular monitoring to achieve optimal outcomes.

Zitieren

APA

Salem, A. E., Abosheaishaa, H., Meribout, S., Zaaya, M., Parraga, C. B., Kumar, K., Cherry, A., Abusuliman, M., Eldesouki, M., Abdelhalim, O., Tsirlin, Y., & Tokayer, A. Z. (2025). Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases. ASIDE Gastroenterology. https://doi.org/10.71079/aside.gi.09242544

Vancouver

Salem AE, Abosheaishaa H, Meribout S, Zaaya M, Parraga CB, Kumar K, et al. Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases. ASIDE Gastroenterology. 2025. doi:10.71079/aside.gi.09242544

BibTeX
@article{Salem2025,
  author = {Salem, Ahmed E. and Abosheaishaa, Hazem and Meribout, Sarah and Zaaya, Morad and Parraga, Carla Barberan and Kumar, Kantash and Cherry, Aye and Abusuliman, Mohammed and Eldesouki, Mohamed and Abdelhalim, Omar and Tsirlin, Yuriy and Tokayer, Aaron Z.},
  title = {Comparative Outcomes of Esophageal Stent Placement in Esophageal Cancer Patients: A Prospective Study of 183 Cases},
  journal = {ASIDE Gastroenterology},
  year = {2025},
  doi = {10.71079/aside.gi.09242544}
}
Kostenlos starten →